Centrient Pharmaceuticals’ Post

Pharma companies tone down ESG mentions, but not ambitions https://lnkd.in/gNgDX54k Pharma companies are scaling back the use of terms like “ESG” and “diversity, equity and inclusion,” much like companies in other industries. In pharma 10-K filings, mentions of ESG, sustainability, or diversity, equity and inclusion [...]

When we recently talked with 800 biopharma professionals across 18 countries to explore the state of sustainability in biopharma, we found out that sustainability is a top business priority to 62% of these over the coming five years. Find out why in our 2024 Global Biopharma Sustainability Review. https://lnkd.in/dyzFBEzy

Guiding 300 pharmacies towards sustainable management based on their carbon report - What action plans? 🌱 Join us to discover the challenges and key steps towards a more sustainable operation for the cooperatives Multipharma and Vpharma. A webinar organised in collaboration with Quentin Van Buylaere (Multipharma), Grégory Van Roy (VPharma), and Alexandre Philippe (IMPACT VALLEY) to address these questions: 📊 What obstacles must be overcome in terms of sustainability, and what are the cooperatives' expectations regarding a carbon report? ✅ What initiatives should be implemented to get everyone on board with this approach? 🔄 What methodology should be used to support businesses and foster a culture of sustainability after the carbon report? Don't miss the opportunity to interact directly with our speakers during this session. Register now! 👉 https://lnkd.in/eNSr3Ba4 Practical information: 📆 Tuesday, July 9th 🕦 11:30 AM - 12:15 PM (20 minutes of presentation and 15 minutes of Q&A) 🗣 Webinar conducted in French

#News: A survey of more than 800 #biopharma executives shows that #sustainability has become an increasingly important priority but that companies are struggling to achieve it and as a result are putting their business at risk. The study—which was conducted by the Danaher Corporation Corporation’s research and manufacturing subsidiary Cytiva and by Financial Times research unit FT Longitude —tabulated the input of execs from firms in 18 different countries. Of the respondents, 26% hold C-suite roles and 30% represent companies that generate more than $1 billion in annual revenue. “We want to drive a conversation around innovation and strategy on sustainability,” Emmanuel Abate , #Cytiva’s sustainability and corporate responsibility chief, said in a release. “These findings highlight where we as an industry must collaborate and push for better progress and prove the benefits of delivering on sustainability targets to employees, customers, and investors.” Read more from Fierce Pharma 👇🏽 https://lnkd.in/eZmEfrKg

Lupin Makes Debut in S&P Global Sustainability Yearbook 2024, Highlighting Commitment to Sustainability. 👉Key Takeaways: ✅ Lupin Limited joins the esteemed S&P Global Sustainability Yearbook 2024 for the first time, showcasing its dedication to environmental, social, and governance (ESG) practices. ✅ With a strong CSA score of 69/100, Lupin ranks within the top 95 percentile of pharmaceutical companies, demonstrating its commitment to sustainable business practices. ✅ This recognition highlights Lupin's focus on creating long-term value for stakeholders while fostering a healthier and more sustainable future. 🗣️Ramesh Swaminathan, Executive Director at Lupin: "This inclusion underscores our commitment to advancing sustainable practices within the pharmaceutical industry and creating long-term value for all stakeholders." 🔗 Read the full article here: https://lnkd.in/dnp3vsSM ----- 👉 Visit www.knowesg.com for more sustainability news, courses, events and ratings 🔗 Discover an extensive network of ESG providers herehttps://lnkd.in/dJskxqFp 👉 Follow us to stay up to day with everything ESG 💚 #sustainablematerials #sustainablemanufacturing #esgnews #sustainabilitynews #knowesg #Lupin #Sustainability #ESG #Pharmaceutical

Roche named among top three most sustainable healthcare companies in the Dow Jones Sustainability Indices 💎The ranking acknowledges Roche’s commitment to sustainability as an integral part of its business strategy 🤝Roche performed particularly well in innovation management, access to healthcare, greenhouse gas emissions, water management, resource efficiency and circularity, labour practice indicators and human rights 🪴This marks the 15th consecutive year that Roche has maintained its leading ranking

🌍 🌍 𝗪𝗵𝗮𝘁 𝗥𝗼𝗹𝗲 𝗖𝗮𝗻 𝘁𝗵𝗲 𝗣𝗵𝗮𝗿𝗺𝗮 𝗜𝗻𝗱𝘂𝘀𝘁𝗿𝘆 𝗣𝗹𝗮𝘆? 𝗝𝗼𝗶𝗻 𝗣𝗵𝗮𝗿𝗺𝗮 𝗦𝘂𝘀𝘁𝗮𝗶𝗻𝗮𝗯𝗶𝗹𝗶𝘁𝘆 𝗗𝗮𝘆𝘀 𝘁𝗼 𝗙𝗶𝗻𝗱 𝗢𝘂𝘁! The world is at a critical juncture, facing unprecedented sustainability challenges, and the pharmaceutical industry has a pivotal role to play. Join us at The Pharma Sustainability Days to delve into this crucial topic and explore how the pharma sector can drive positive change. 𝗪𝗵𝗮𝘁 𝘆𝗼𝘂 𝗰𝗮𝗻 𝗲𝘅𝗽𝗲𝗰𝘁: 🌱 𝗘𝗻𝘃𝗶𝗿𝗼𝗻𝗺𝗲𝗻𝘁𝗮𝗹 𝗜𝗺𝗽𝗮𝗰𝘁 Learn about the environmental footprint of pharmaceutical manufacturing and discover sustainable practices to reduce it. 👥 𝗦𝗼𝗰𝗶𝗮𝗹 𝗜𝗺𝗽𝗮𝗰𝘁 Explore the social responsibility of pharmaceutical companies and their impact on communities worldwide. 💰 𝗘𝗰𝗼𝗻𝗼𝗺𝗶𝗰 𝗜𝗺𝗽𝗮𝗰𝘁 Understand the economic implications of sustainability initiatives in the pharma industry and how they can benefit both businesses and society. 🎯 𝗨𝗿𝗴𝗲𝗻𝗰𝘆 𝗼𝗳 𝗔𝗰𝘁𝗶𝗼𝗻 Hear from experts about the urgent need for action in addressing global sustainability challenges and the role that the pharma industry can play in driving meaningful change. Let's come together to explore solutions, share insights, and take action towards a more sustainable future. Register now to secure your spot at Pharma Sustainability Days and be part of the conversation! #ThePharmaSustainabilityDays #GlobalGoals #SustainableFuture #PharmaIndustry #Sustainability 🌿🌎💡

Read the inspiring collaboration story between AstraZeneca and its supplier MINAKEM who are both partnering with EcoVadis to advance sustainable practices including sustainable procurement, climate action, and diversity, equity, and inclusion (DEI), showcasing ongoing progress and commitment to sustainability goals. Find the case study below. https://ecovad.is/49h6Nfv #EcoVadisSuccessStory #Collaboration #DEI #SustainablePractices

Here it is: We released our first #Sustainability Report, underlining the topic’s important role as part of our long-term #growth strategy. It showcases the dedication of SCHOTT Pharma toward creating a positive impact on the environment, society, and our #business – from reducing our carbon footprint to social responsibility. I want to thank Arne Kloke and the entire team, stakeholders, and partners who've made this milestone a reality. Together, we're shaping a future where sustainability is not just a choice but a way of doing business responsibly in the #pharma industry. #BecauseHumanHealthMatters https://lnkd.in/d_4zJsJX

We just released our 2023 Amgen ESG Report. Environmental Sustainability (Healthy Planet section) highlights are: 1. We remain on track to meet our 2027 Ambition to dramatically reduce carbon, water, and waste footprints. 2. We advanced Amgen EcovationTM — our approach to innovative and sustainable manufacturing — with our newest biomanufacturing facility in Ohio that was built to LEED Gold standard and includes solar arrays. 3. We formalized our expectations of engagement with suppliers to support their adoption of science-based targets. This is important as more than an estimated 90% of our greenhouse gas emissions come from our value chain. #mycompany #sustainability #innovation https://lnkd.in/g89fRurs